Frauke Muecksch

15.8k total citations · 3 hit papers
20 papers, 1.5k citations indexed

About

Frauke Muecksch is a scholar working on Infectious Diseases, Molecular Biology and Virology. According to data from OpenAlex, Frauke Muecksch has authored 20 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 4 papers in Molecular Biology and 3 papers in Virology. Recurrent topics in Frauke Muecksch's work include SARS-CoV-2 and COVID-19 Research (15 papers), COVID-19 Clinical Research Studies (9 papers) and SARS-CoV-2 detection and testing (7 papers). Frauke Muecksch is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (15 papers), COVID-19 Clinical Research Studies (9 papers) and SARS-CoV-2 detection and testing (7 papers). Frauke Muecksch collaborates with scholars based in United States, Germany and United Kingdom. Frauke Muecksch's co-authors include Paul D. Bieniasz, Théodora Hatziioannou, Michel C. Nussenzweig, Christian Gaebler, Davide F. Robbiani, Julio C. C. Lorenzi, Fabian Schmidt, Zijun Wang, Justin DaSilva and Robert B. Darnell and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Frauke Muecksch

19 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vaccine Breakthrough Infections with SARS-CoV-2 Variants

2021 440 citations Ezgi Hacisuleyman, Caryn Hale et al. New England Journal of Medicine profile →
Enhanced SARS-CoV-2 neutralization by dimeric IgA

2020 294 citations Zijun Wang, Julio C. C. Lorenzi et al. Science Translational Medicine profile →
Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies

2021 205 citations Allison J. Greaney, Tyler N. Starr et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frauke Muecksch United States	12	1.3k	322	198	164	151	20	1.5k
Amy Kempf Germany	12	1.5k 1.1×	380 1.2×	160 0.8×	134 0.8×	206 1.4×	27	1.6k
Luise Graichen Germany	10	1.4k 1.1×	356 1.1×	146 0.7×	130 0.8×	210 1.4×	21	1.6k
Kerri St. Denis United States	12	1.7k 1.3×	486 1.5×	291 1.5×	102 0.6×	233 1.5×	18	1.9k
Rachel Eguia United States	12	1.3k 1.0×	446 1.4×	195 1.0×	166 1.0×	232 1.5×	13	1.6k
Philip Meade United States	11	1.2k 0.9×	162 0.5×	229 1.2×	129 0.8×	117 0.8×	23	1.5k
Jinal N. Bhiman South Africa	13	937 0.7×	411 1.3×	408 2.1×	240 1.5×	107 0.7×	29	1.5k
Evan C. Lam United States	14	2.1k 1.6×	558 1.7×	351 1.8×	127 0.8×	277 1.8×	23	2.4k
Jared Feldman United States	13	2.2k 1.6×	702 2.2×	419 2.1×	250 1.5×	299 2.0×	24	2.6k
Daniel Stadlbauer United States	18	1.4k 1.0×	285 0.9×	422 2.1×	173 1.1×	119 0.8×	31	2.1k
Anna-Sophie Moldenhauer Germany	12	873 0.7×	221 0.7×	140 0.7×	65 0.4×	112 0.7×	14	1.0k

Countries citing papers authored by Frauke Muecksch

Since Specialization

Citations

This map shows the geographic impact of Frauke Muecksch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frauke Muecksch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frauke Muecksch more than expected).

Fields of papers citing papers by Frauke Muecksch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frauke Muecksch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frauke Muecksch. The network helps show where Frauke Muecksch may publish in the future.

Co-authorship network of co-authors of Frauke Muecksch

This figure shows the co-authorship network connecting the top 25 collaborators of Frauke Muecksch. A scholar is included among the top collaborators of Frauke Muecksch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frauke Muecksch. Frauke Muecksch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lenart, Klara, et al.. (2025). PRISM-Seq: An Ultra-sensitive Sequencing Approach For Mapping Lentiviral Integration Sites. bioRxiv (Cold Spring Harbor Laboratory).

Muecksch, Frauke, Severina Klaus, Vibor Laketa, Bárbara Müller, & Hans‐Georg Kräusslich. (2024). Probing Gag-Env dynamics at HIV-1 assembly sites using live-cell microscopy. Journal of Virology. 98(9). e0064924–e0064924. 1 indexed citations

Bittar, Cíntia, Thiago Y. Oliveira, Amy S. Huang, et al.. (2024). Transcription of HIV-1 at sites of intact latent provirus integration. The Journal of Experimental Medicine. 221(9). 6 indexed citations

Zhang, Fengwen, Fabian Schmidt, Frauke Muecksch, et al.. (2024). SARS-CoV-2 spike glycosylation affects function and neutralization sensitivity. mBio. 15(2). e0167223–e0167223. 14 indexed citations

Schmidt, Fabian, Zijun Wang, Alice Cho, et al.. (2023). Epistasis lowers the genetic barrier to SARS-CoV-2 neutralizing antibody escape. Nature Communications. 14(1). 302–302. 25 indexed citations

Wang, Zijun, Frauke Muecksch, Marie Canis, et al.. (2023). Antigen presentation dynamics shape the antibody response to variants like SARS-CoV-2 Omicron after multiple vaccinations with the original strain. Cell Reports. 42(4). 112256–112256. 22 indexed citations

Gaebler, Christian, Justin DaSilva, Eva Bednarski, et al.. (2022). Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization After Messenger RNA Vaccination and Variant Breakthrough Infection. Open Forum Infectious Diseases. 9(7). ofac227–ofac227. 3 indexed citations

Muecksch, Frauke, Helen Wise, Kate Templeton, et al.. (2022). Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: a serological analysis. The Lancet Microbe. 3(7). e493–e502. 23 indexed citations

Wise, Helen, Jennifer Simpson, Becky Batchelor, et al.. (2022). Evaluation of SARS-CoV-2 antibody point of care devices in the laboratory and clinical setting. PLoS ONE. 17(3). e0266086–e0266086. 6 indexed citations

10.

Jette, Claudia A., Alexander A. Cohen, Priyanthi N.P. Gnanapragasam, et al.. (2021). Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies. Cell Reports. 36(13). 109760–109760. 45 indexed citations

11.

McDonald, Lindsay T., Helen Wise, Frauke Muecksch, et al.. (2021). Comparison of SARS-CoV-2 serological assays for use in epidemiological surveillance in Scotland. SHILAP Revista de lepidopterología. 1(3). 100028–100028. 1 indexed citations

12.

Greaney, Allison J., Tyler N. Starr, Christopher O. Barnes, et al.. (2021). Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies. Nature Communications. 12(1). 4196–4196. 205 indexed citations breakdown →

13.

Bou‐Nader, Charles, Frauke Muecksch, Ashley York, et al.. (2021). HIV-1 matrix-tRNA complex structure reveals basis for host control of Gag localization. Cell Host & Microbe. 29(9). 1421–1436.e7. 34 indexed citations

14.

Hacisuleyman, Ezgi, Caryn Hale, Yuhki Saito, et al.. (2021). Vaccine Breakthrough Infections with SARS-CoV-2 Variants. New England Journal of Medicine. 384(23). 2212–2218. 440 indexed citations breakdown →

15.

Pan, Chun‐Hao, William E. Diehl, Jamie L. Romeiser, et al.. (2021). Neutralizing activity to SARS‐CoV‐2 of convalescent and control plasma used in a randomized controlled trial. Transfusion. 61(5). 1363–1369. 9 indexed citations

16.

Schäfer, Alexandra, Frauke Muecksch, Julio C. C. Lorenzi, et al.. (2020). Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo. The Journal of Experimental Medicine. 218(3). 157 indexed citations

17.

Muecksch, Frauke, Helen Wise, Becky Batchelor, et al.. (2020). Longitudinal Serological Analysis and Neutralizing Antibody Levels in Coronavirus Disease 2019 Convalescent Patients. The Journal of Infectious Diseases. 223(3). 389–398. 153 indexed citations

18.

Luchsinger, Larry L., Frauke Muecksch, Yiska Weisblum, et al.. (2020). Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients. Journal of Clinical Microbiology. 58(12). 101 indexed citations

19.

Wang, Zijun, Julio C. C. Lorenzi, Frauke Muecksch, et al.. (2020). Enhanced SARS-CoV-2 neutralization by dimeric IgA. Science Translational Medicine. 13(577). 294 indexed citations breakdown →

20.

Muecksch, Frauke, et al.. (2012). A comparison of two methods to assess audience-induced changes in male mate choice. Current Zoology. 58(1). 84–94. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact